Description
MK-2866, sold under the name Ostarine, is a selective androgen receptor modulator (SARM) primarily researched for its potential to treat muscle wasting and osteoporosis. It is designed to promote lean muscle mass and improve physical function in individuals suffering from conditions that lead to muscle loss. Ostarine is administered orally, typically in capsule form.
Side effects of ostarine may include mild symptoms such as headaches, nausea, and changes in libido. As a selective androgen receptor modulator, ostarine selectively targets androgen receptors in muscle and bone tissues, promoting anabolic activity while minimizing androgenic effects in other tissues. This selectivity makes it an attractive option for those looking to enhance muscle growth without the side effects commonly associated with traditional anabolic steroids.
Ostarine was developed in the early 2000s and has been the subject of various clinical trials to assess its efficacy and safety. While it is not currently approved for medical use by regulatory agencies, it has gained popularity in the bodybuilding and athletic communities for its potential to improve physique and performance.
Medical uses
Ostarine is primarily investigated for the treatment of muscle wasting conditions and osteoporosis. It has shown promise in clinical trials for promoting lean muscle mass and improving physical function in populations at risk of muscle loss, such as the elderly or those with chronic illnesses. Although it is not approved for human use, it is often used off-label by athletes and bodybuilders seeking to enhance performance and body composition.
